Lack of Clinical Trial Participants Slowing Cancer Drug Development

Lack of Clinical Trial Participants Slowing Cancer Drug Development

Hundreds of cancer drugs are in the pipeline with the potential to save millions of lives, and make even more inroads into this dreaded disease. But may of the tests are stalled, due to a lack of people willing to participate in the clinical trials which are required before a cancer drug can win approval, News Radio 1200 WOAI reports. …